Hydroxyapatite nanoparticles as a vehicle for drug delivery approach in Alzheimer's disease
Hydroxyapatite (HAp) nanoparticles are emerging as a promising drug delivery vehicle for Alzheimer’s Disease (AD) treatment due to their biocompatibility , stability , & surface versatility. AD is a progressive neurodegenerative condition characterize
Authors
- Sushil Kumar Sharma (ORCID: https://orcid.org/0000-0001-7591-2029)
- Awalendra K. Thakur (ORCID: https://orcid.org/0000-0002-8465-9763)
- Pallavi Dan (ORCID: https://orcid.org/0000-0002-5814-2912)
- S. Kaur
- Harsimran Kaur (ORCID: https://orcid.org/0000-0002-5671-9482)
- Osaid Rizvi SM
Institutions
- Chandigarh University (IN)
Publication Details
- Published
- 2025-08-29
- DOI
- https://doi.org/10.22541/au.175647833.34740198/v1
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00